CAR T-Cell Therapy and Bispecific Antibodies in Mantle Cell Lymphoma

被引：0
|
作者：
Kallam, Avyakta [1 ]
Danilov, Alexey [1 ]
Phillips, Tycel J. [1 ]
机构：
[1] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
High risk; CRS; ICANS; bruton tyrosine kinase inhibitor; venetoclax;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S124 / S125
页数：2
相关论文
共 50 条
  • [31] KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
    Wang, Michael
    Munoz, Javier
    Goy, Andre
    Locke, Frederick L.
    Jacobson, Caron A.
    Hill, Brian T.
    Timmerman, John M.
    Holmes, Houston
    Jaglowski, Samantha
    Flinn, Ian W.
    McSweeney, Peter A.
    Miklos, David B.
    Pagel, John M.
    Kersten, Marie-Jose
    Milpied, Noel
    Fung, Henry
    Topp, Max S.
    Houot, Roch
    Beitinjaneh, Amer
    Peng, Weimin
    Zheng, Lianqing
    Rossi, John M.
    Jain, Rajul K.
    Rao, Arati V.
    Reagan, Patrick M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (14): : 1331 - 1342
  • [32] Chimeric antigen receptor (CAR) T-cell treatment for mantle cell lymphoma (MCL)
    Tbakhi, Bushra
    Reagan, Patrick M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [33] CAR T-Cell Therapy in Large B-Cell Lymphoma
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (11): : 1065 - 1065
  • [34] Exploring BiTE-Integrated CAR T-Cell Therapy to Overcome Tumor Antigen Escape and Reinforce CAR-T Therapy in Mantle Cell Lymphoma
    Crutchfield, Grace Glass
    Liu, Yang
    Yan, Fangfang
    Li, Xiaolin
    Lee, Heng-Huan
    Wang, Michael
    Yao, Yixin
    BLOOD, 2023, 142
  • [35] T-Cell Lymphoma From CAR T-Cell Therapy-A New Safety Notice
    Prasad, Vinay
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (05): : 389 - 390
  • [36] Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma
    Corey M. Munger
    Ganapati V. Hegde
    Dennis D. Weisenburger
    Julie M. Vose
    Shantaram S. Joshi
    Cancer Immunology, Immunotherapy, 2012, 61 : 1819 - 1832
  • [37] Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma
    Munger, Corey M.
    Hegde, Ganapati V.
    Weisenburger, Dennis D.
    Vose, Julie M.
    Joshi, Shantaram S.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (10) : 1819 - 1832
  • [38] Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy
    Qin, Xiaojing
    Ning, Wenjing
    Liu, Han
    Liu, Xue
    Luo, Wenxin
    Xia, Ningshao
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (06) : 2361 - 2377
  • [39] Bispecific antibodies for polyclonal T-cell engagement
    Baeuerle, PA
    Kufer, P
    Lutterbüse, R
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (04) : 413 - 419
  • [40] Recent advances in CAR T-cell therapy for lymphoma in China
    Che, Yuxuan
    Sun, Xiuhua
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (10): : 2793 - 2800
12345